Crossmark

In-vitro antibacterial, antioxidant and anti-inflammatory and In-silico ADMET, molecular docking study on Hardwickia binata phytocompunds with potential inhibitor of skin cancer protein

Crossref DOI link: https://doi.org/10.1007/s40203-023-00163-3

Published Online: 2023-09-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Manimegalai, Peraman

Selvam, Kuppusamy

Prakash, Palanisamy

Kirubakaran, Dharmalingam

Shivakumar, Muthugounder Subaramanian

SenthilNathan, Sengottayan
License Information

Text and Data Mining valid from 2023-09-23

Version of Record valid from 2023-09-23
More Information

Article History

Received: 15 May 2023

Accepted: 2 September 2023

First Online: 23 September 2023

Declarations

:

: The authors declare that they have no conflict of interest.

: Ethical approval not applicable. Because this study was not conducted directly in any human or animal projects. In our experiment we use a human blood sample collected from a normal healthy volunteer. In our country the collection and use of the blood sample from a normal healthy volunteer without any treatment did not require ethical approval.

Document is current

Any future updates will be listed below